$ACAD Company News This tiny mutual fund is no. 1 for

New Post Public Reply Private Reply Replies (0) Message Board

Feb 26, 2014 at 12:57 PM

$ACAD Company News

This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Despite Fed concerns, technicals support bull case 1:16 p.m. Sept. 17, 2013 - Michael Ashbaugh
Despite Fed concerns, technicals support bull case 12:02 p.m. Sept. 17, 2013 - Michael Ashbaugh
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
Charting the S&P 500’s break to all-time highs 11:47 a.m. Aug. 6, 2013 - Michael Ashbaugh
Longer-term technical risk points higher 11:32 a.m. Aug. 6, 2013 - Michael Ashbaugh
7 gut checks before the stock market's opening bell 5:56 a.m. July 30, 2013 - Shawn Langlois
Charting a strong third-quarter start 11:23 a.m. July 16, 2013 - Michael Ashbaugh
Charting a strong third-quarter start 11:17 a.m. July 16, 2013 - Michael Ashbaugh
Looking for the choicest opportunity 12:37 p.m. June 11, 2013 - The Trading Deck
Declines often spell opportunity 1:11 p.m. June 6, 2013 - The Trading Deck
Don't fight the tape 10:27 a.m. May 28, 2013 - The Trading Deck
Charting the S&P’s uptrend, and its next hurdle 10:55 a.m. April 23, 2013 - Michael Ashbaugh
Charting the S&P’s uptrend, and its next hurdle 10:25 a.m. April 23, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Dow, S&P pull in from record highs 10:15 a.m. April 12, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 11:01 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 10:50 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 vies for record closing high 11:19 a.m. March 28, 2013 - Michael Ashbaugh
Acadia Pharma up 10% in premarket 9:17 a.m. Dec. 12, 2012 - Steve Gelsi

ACADIA Pharmaceuticals (ACAD) Jumps: Stock Rises 17.3% - Tale of the Tape 9:18 a.m. Feb. 24, 2014 - Zacks.com
Watch Out: Barbarians At The Gate For ACADIA Pharmaceuticals (ACAD) 11:19 a.m. Feb. 21, 2014 - TheStreet.com
Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming 8:31 a.m. Feb. 11, 2014 - Seeking Alpha
Commit To Purchase Acadia Pharmaceuticals At $15, Earn 17.9% Annualized Using Options 12:00 p.m. Feb. 5, 2014 - TheStreet.com
Cramer's Lightning Round - Archer Daniels Midland Is Much Ado About Nothing (1/30/14) 6:22 a.m. Jan. 31, 2014 - Seeking Alpha
'Mad Money' Lightning Round: Don't Bet on Boyd Gaming 6:00 a.m. Jan. 31, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Social, Mobile, Cloud Are Buys 8:19 p.m. Jan. 30, 2014 - TheStreet.com
Cramer's Lightning Round - Agilent Is Sensational (1/28/14) 5:16 a.m. Jan. 29, 2014 - Seeking Alpha
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Jan. 28, 2014 - Seeking Alpha
Notes From One-On-One Meetings During San Fran Biotech Week - Day 1 9:05 a.m. Jan. 23, 2014 - Seeking Alpha
Acadia slides as SA article paints grim picture 12:39 p.m. Jan. 7, 2014 - Seeking Alpha
Healthcare Stocks To Avoid This Year 10:08 a.m. Jan. 7, 2014 - Seeking Alpha
4 Stocks That Could See Significant Gains In 2014 2:35 p.m. Jan. 6, 2014 - Seeking Alpha
Acadia Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days 11:52 a.m. Jan. 6, 2014 - Seeking Alpha
A Tiny-Stock Fund Is No. 1 for 2013 4:28 p.m. Jan. 5, 2014 - WSJ.com
Top Stocks Of 2013 Run Gamut: Solar, Drugs, Tech, TV 5:59 p.m. Jan. 2, 2014 - Investors Business Daily
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Taking A Look At A Few Of The Top Performers Of 2013 12:27 p.m. Dec. 30, 2013 - Seeking Alpha
The Billion-Dollar Biotech Club: Speculation Trumped Risk 9:19 a.m. Dec. 30, 2013 - TheStreet.com
Acadia: The Best Hope For Parkinson's Psychosis Sufferers 4:21 p.m. Dec. 27, 2013 - Seeking Alpha

ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2013 Financial Results on February 27, 2014 9:01 a.m. Feb. 20, 2014 - BusinessWire - BZX
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch 8:00 a.m. Dec. 25, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Proposed M&A's, Conference Schedules, Health Awareness Programs, Prestigious Recognitions and FDA Designations - Research Report on Health Management, Acadia, Health Net, NuVasive and Portola 8:00 a.m. Nov. 29, 2013 - PR Newswire
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences 9:00 a.m. Nov. 26, 2013 - BusinessWire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
Earnings, Trend Analysis: The Dow Chemical, Turquoise Hill Resources, ACADIA Pharmaceuticals, E Commerce China Dangdang, Yum! Brands 9:35 a.m. Nov. 15, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Initiation of Phase II Trial with Pimavanserin for Alzheimer's Disease Psychosis 9:00 a.m. Nov. 14, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:29 a.m. Nov. 7, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:01 p.m. Nov. 6, 2013 - BusinessWire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Publication in The Lancet of Pivotal Phase III Parkinson's Disease Psychosis Trial with Pimavanserin 7:40 p.m. Oct. 31, 2013 - BusinessWire
Under The Radar Big Pharma Partnership Opportunity for Zalicus,Targacept and ACADIA 4:17 a.m. Oct. 31, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 6, 2013 8:00 a.m. Oct. 30, 2013 - BusinessWire
Financial Results & Release Schedules, Stock Performance Update, and New Clinical Trials - Research Report on Amgen, Boston Scientific, ACADIA Pharmaceuticals, Seattle Genetics, and Volcano 8:00 a.m. Oct. 29, 2013 - PR Newswire
Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. 8:05 a.m. Oct. 21, 2013 - PR Newswire
Critical Alerts For SunPower, Starbucks, ACADIA Pharmaceuticals, Opko Health, and Cytokinetics Released By InvestorsObserver 8:31 a.m. Oct. 16, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Baystate Health Expands: A New Chapter with Mercy

Baystate Health Moves Forward with Strategic Integration Well, here's a tale that's as much about legacy as it is about progress. Baystate Health has brought Baystate Mercy Hospital into its fold, blending history with future prospects. This integration, folks, isn't just a merger—it's a downright overhaul of how healthcare operates in Western Massachusetts. We’re...

Termite Swarmers: Essential Clues and Action Steps

Understanding the Intrusive Nature of Termite Swarmers When it comes to creepy crawlies wreaking havoc on your beloved abode, termites are the stealthy troublemakers you need to keep an eye out for. Just because you catch a glimpse of them doesn't mean the damage is obvious or minimal. Spotting the Culprits: Termites vs. Ants Identifying what you're up against is the...

Dutch Bros Pours Holiday Cheer with New Festive Menu

New Festive Offerings from Dutch Bros Kicking off the holiday season with a splash of vibrant flavors, Dutch Bros is shaking up the menu with some fresh, festive entries. Two new drink concoctions hit the stage alongside a themed delectable treat, and for those traditionalists, perennial favorites make a triumphant return. Dutch Bros Expands Its Vibrant Lineup It's not...

Gildan Faces Class Action Deadline Over Fraud Claims

Gildan's Legal Storm: Fraud Allegations When news hits about a big player like Gildan Activewear (NYSE: GIL) facing a class-action lawsuit, it's like a thunderstorm for investors who traded their stocks between February 19, 2025, and June 15, 2026. This lawsuit alleges what we some might call classic financial engineering—channel stuffing to be precise—that’s got...

CJ BIO's Bold Steps for Sustainable Animal Nutrition

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Bahrain's USD 3.89 Billion Investment Surge in 2026

Bahrain's Bold Moves to Woo Global Investment Bahrain's never been one to tiptoe around, huh? With a whopping USD 3.89 billion on the line, the Kingdom's flashing its neon sign to investors: "Open for Business!" These Golden License projects aren't just a few shiny new ventures — they're bridging aviation logistics, real estate, and the tech sector. Talk about ambition....

Naviu's AI Travel Guide: Revolutionizing Japan Tours

A New Era of Touring Japan: Meet Naviu Alright, travelers, strap in—Naviu is about to flip your trip to Japan upside down. Launching November 1st, 2026, this AI-powered augmented reality travel companion is trying to make exploring Japan easier than ever. Behind this innovative gem is TANGLE Inc., working with technology so cutting-edge, it's practically slicing through...

Bass Angler Matt Robertson Reels in Record $1.25M Prize

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Isinwheel's 2027 E-Mobility Pitch: Beyond Resolutions

Embracing the E-Mobility Shift Here we are at the tail end of 2026, and isinwheel is riding high on the wave of New Year resolutions with their hefty e-mobility lineup. It's not just about buying the gear—it's about tackling our reliance on gas-guzzlers with electric scooters and bikes as our trusty steeds. "Reduce car trips? More greenery in your commute? These aren't...

SICO Snags $1.6B in New Investor Mandates for 2026

SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...